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Abstract: NRF2 is a redox-sensitive transcription factor that depending on the duration or magnitude
of the stress, either translocates to the nucleus (beneficial) or is degraded in the cytosol (harmful).
However, the role of NRF2-based mechanism(s) under ethanol (E)-induced developmental toxicity
in the placental context remains unknown. Here, we used a rat prenatal model of maternal alcohol
stress consisting of intermittent ethanol vapor (IEV) daily from GD11 to GD20 with a 6 h ON/18 h
OFF in a vapor chamber and in vitro placental model consisting of HTR-8 trophoblasts exposed to
86 mM of E for either 24 h or 48 h. The role of NRF2 was evaluated through the NRF2-transactivation
reporter assay, qRT-PCR, and Western blotting for NRF2 and cell growth-promoting protein, and cell
proliferation assay. In utero and in vitro E decreased the nuclear NRF2 content and diminished its
transactivation ability along with dysregulation of the proliferation indices, PCNA, CYCLIN-D1,
and p21. This was associated with a ~50% reduction in cell proliferation in vitro in trophoblasts.
Interestingly, this was found to be partially rescued by ectopic Nrf2 overexpression. These results
indicate that ethanol-induced dysregulation of NRF2 coordinately regulates PCNA/CYCLIN-D1/p21
involving growth network, at least partially to set a stage for placental perturbations.
Keywords: NRF2; placenta; ethanol; trophoblasts; prenatal alcohol; CYCLIN-D1; p21

1. Introduction
Prenatal alcohol exposure is generally considered to be the major single cause of preventable birth
defects and developmental anomalies [1,2]. The earliest descriptions of toxic effects of ethanol (E) on
the human fetus and its postnatal development are “impaired growth”, altered brain morphology,
craniofacial malformations, cardiac septal defects, and others [3–6]. Subsequent studies utilizing animal
models to define this phenomenon consistently documented the growth perturbant response to in
utero and early postnatal E exposures [7,8]. Thus, potentially central to alcohol-induced multifactorial
fetotoxic responses are the placenta’s role in transferring nutrients and oxygen to the growing fetus
and regulating the maternal–fetal interaction. This concept has been reinforced by a body of studies
illustrating E-related damage to the survival (apoptotic death) and differentiation of placental cells
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that may be mechanistically connected to its altered morphology, function (transport and endocrine),
stress signaling response (shift in redox and inflammatory balance), and increased risk of placental
abruption [9–13]. Importantly, following any stress, cellular-level responses in the placenta, for instance,
alterations in the placental gene expressions, placenta-derived diffusible factors (secretome) such as
brain-derived neurotrophic factor (BDNF), insulin-like growth factor 1 & 2 (IGF1, IGF2), serotonin,
dopamine, norepinephrine, hormones, as well as oxidative stress (OS) can alone or in combinations,
biologically impact maternal physiology as well as fetal neurodevelopment processes [14–19]. Of note,
alcohol exposure can provoke all the above cellular impacts. Relevant to the current studies, others
and we have identified numerous E-related perturbations of cellular events/signaling pathways
that underlie fetal brain and placental cell survival and function [12,13,20–24]. Thus, despite being
an ephemeral organ, the placenta’s vital role in the adaptive signaling to program whole system
development (fetal growth) renders it a multifunctional organ beyond a mere passive channel for
bidirectional maternal/fetal exchange.
A healthy placenta is capable of generating significant base-line levels of reactive oxygen species
(ROS) to execute specific physiological functions [25,26]. However, a myriad of exogenous causes
of OS such as stress, inflammation, or xenobiotics, in the absence of genetic abnormalities have
been shown to modify specific gene/molecular patterns or decrease the antioxidant capacity that can
adversely amplify ROS levels and lead to placental dysfunction [9,12,13,16,27–29]. E-induced OS
has been addressed as a compelling mechanism/target in the placenta and human placental villi [29],
as previously demonstrated by us for liver and brain [20,21,30–32]. Notably, this is a setting where
perturbations in the cell cycle, proliferation, migration and cell morphogenesis are impacted [4,13].
The result of such a structure-function alteration at the placental level due to in utero insult might
hinder their response and predispose the fetus and mother to an immediate as well as lasting health
consequences. Thus, understanding how specific placental cytoprotective signaling mechanisms
are altered in response to alcohol could provide critical insight into means to regulate the in utero
environment to prevent adverse impacts on fetal development.
Relevantly, several lines of evidence have established that the redox-dependent transcription factor
NF-E2 p45-related factor 2 (Nrf2; gene name Nfe2l2) integrates signaling from multiple inputs, including
growth factors, nutrient, oxygen, and energy levels and positively regulates the genes encoding proteins
that govern cell growth, metabolism, redox homeostasis, drug/xenobiotic detoxification, DNA repair,
etc. [33]. Others and we have previously shown that activation of Nrf2/antioxidant pathway is
essential to prevent alcohol-induced oxidative damage and related redox homeostasis in different
model systems [20,34–36]. Given a prominent role for oxidative and growth signaling perturbations in
alcohol-induced developmental toxicity together with an incomplete understanding of origin(s) of
placental mechanisms, we investigated whether alcohol disrupts the interplay between Nrf2/redox
pathway and growth network genes in the placenta. Using both an in vivo rat prenatal model of
maternal alcohol stress and a placental cell in vitro acute E exposure model, we found that in utero and
in vitro E exposure dysregulated NRF2 antioxidant signaling. This was associated with a significant
reduction in the expression of proliferation markers, PCNA and CYCLIN-D1. In contrast, p21waf1/cip1,
a key interactor of PCNA and a cell cycle progression inhibitor was significantly increased by E. All of
these events could be connected to inhibition of cell growth in vitro. Additionally, cDNA-mediated Nrf2
overexpression partially rescued the E-impaired NRF2-transactivation ability and cell proliferation.
2. Materials and Methods
2.1. Materials
RPMI medium, L-glutamine, penicillin-streptomycin, and trypsin-EDTA were obtained from
Gibco (Grand Island, NY, USA). Fetal bovine serum (FBS) was obtained from Atlanta Biologicals
(Lawrenceville, GA, USA). Plasmocin was purchased from Invivogen (San Diego, CA, USA). BCA
Protein assay reagent, SuperSignal West Pico chemiluminescence kit, NuPAGE 4%–12% Bis-Tris
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gels, was bought from Thermofisher (Rockford, IL, USA) respectively. Polyvinylidene difluoride
(PVDF) membrane, iScript cDNA synthesis kit, and iTaq universal probes supermix were from Biorad
Laboratories (Hercules, CA, USA). TriZol was purchased from Invitrogen (Carlsbad, CA, USA).
Antibodies for NRF2 (Abcam, Cambridge, MA, USA), CYCLIN D1 (Cell Signaling Technology, Beverly,
MA, USA); PCNA, p21, KEAP1, LAMIN-B1, H3, and GAPDH (Santa Cruz Biotechnologies, Santa Cruz,
CA, USA); and ACTIN were from Sigma-Aldrich (St. Louis, MO, USA). Horse anti-mouse IgG-HRP, goat
anti-rabbit, and IgG-HRP were obtained from Cell Signaling Technology (Beverly, MA, USA). HyBlot
CL autoradiography film was got from Denville Scientific (Metuchen, NJ, USA). Trans IT-20/20 DNA
transfection agent was obtained from Mirus Bio (Madison, WI, USA). TaqMan gene expression assays
consisting of the primers and probes specific for different genes were from Applied Biosystems (Table 1)
(Foster City, CA, USA). 2-20 70 Dichlorofluorescin diacetate (DCF-DA), tertiary butylhydroquinone
(t-BHQ), protease cocktail, 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT),
and all other reagents were purchased from Sigma-Aldrich (St. Louis, MO, USA).
Table 1. List of Taqman gene primer-probe.
Gene

Assay ID

Fluorophore

Gclc
Gclm
Gsr
Ho-1
Nqo1
Nfe2l2
Gapdh

Rn00689046_m1
Rn00568900_m1
Rn01482159_m1
Rn01536933_m1
Rn00566528_m1
Rn00477784_m1
Rn01775763_g1

FAM
FAM
FAM
FAM
FAM
FAM
VIC

2.2. HTR-8 sv/neo Trophoblast Cultures and Ethanol Treatment
The immortalized extravillous trophoblasts line HTR-8/SVneo obtained from human placenta
(ATCC, Manassas, VA. USA) was cultured in RPMI-1640 media containing 10% FBS supplemented
with 200 mM l-glutamine, 100 Units/mL of penicillin/100 µg/mL streptomycin and plasmocin
(5 µg/mL). Cells were grown in a monolayer at 37 ◦ C in a humidified incubator with 95% air
and 5% CO2 . 24 h post-seeding the cells were either subjected to transfection experiments or E
treatment. The concentration of E was 4 mg/mL (86 mM) a BAC that occurs in heavy drinkers and
which elicits toxic responses in multiple animal models [20,37–40]. To maintain this ethanol level
in culture media, the E-treated plates were incubated for 24 h or 48 h in an incubator pre-saturated
with alcohol by placing a beaker filled with E for at least for 24 h [41,42], while the control cells
were maintained in the normal incubator. These cells were shown to exhibit primary cytotrophoblast
phenotypic markers (cytokeratin, human chorionic gonadotropin, and type IV collagenase) and exhibit
response patterns similar to the former upon changing maternal environment [43,44]. Importantly,
HTR-8/sv neo cells are regarded as an appropriate cell culture model to study normal trophoblast and
placental biology as they are non-tumorigenic cells unlike the other widely used placental cell types,
JEG3, BeWo, and JAR, which are choriocarcinoma cells.
2.3. In Vivo Prenatal Alcohol Exposure Model
2.3.1. Rationale for the Timeline Used
The timeline of alcohol exposure in this study was between gestational days (GD) 11–20, a secondtrimester equivalent in humans. The rationale for using this timeline is the first step towards one of
our long-term goals to understand the influence of placental changes on the neurodevelopmental
process during prenatal alcohol exposure. In particular, gestational day (GD) 11–20 is an active phase
of fetal CNS development including but not limited to histogenesis, neurogenesis, vasculogenesis,
angiogenesis, proliferation and migration, and differentiation [45–47]. Importantly, in mice, only by
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2.5. Luciferase Assay
Transfection was performed in serum free, antibiotic free media as above (Section 2.4) and 1.5 h
post-transfection media containing serum and antibiotics was added and the plates were returned to
incubator. Following 24 h of transfection, E was exposed for additional 48 h. For the tBHQ experiments,
50 µM of tBHQ was added to cells when serum supplemented media was added post 1.5 h transfection.
Twenty-four hours after tBHQ addition, E was added as above for the 48 h exposure. At the end of the
experiments, luciferase reporter activity was assessed using dual-luciferase reporter assay system as
per the manufacturer’s recommendation (Promega, Madison, WI, USA). The luciferase activity was
measured using Glomax 20/20 luminometer (Promega, Madison, WI, USA) was normalized to renilla
activity or protein concentration obtained from the corresponding samples.
2.6. RNA Extraction and Real-Time qRT-PCR Analysis
Total RNA was isolated from HTR-8 vs/neo cells or placental tissue using TRIzol reagent according
to the manufacturer’s protocol (Invitrogen, Carlsbad, CA, USA). After eliminating the genomic DNA,
1.5 µg of total RNA was reverse transcribed using iScript cDNA synthesis kit (BioRad, Hercules,
CA, USA). For the RT-PCR reaction, 1/10th of the cDNA was used in a final volume of 20 µL which
contained 10 µL of iTaq Universal probes supermix, and 20 pmol of the respective primer/probe mix
with the protocol initial denaturation step of 95 ◦ C for 30 s which was followed by 40 PCR cycles (95 ◦ C)
for 5 s and 60 ◦ C for 30 s. The relative expression of Nrf2, Gclc, Gclm, Gsr, Ho-1, Nqo-1 was assessed by
normalizing it to the housekeeping gene Gapdh and was then compared with controls. The relative fold
variation in mRNA expression was calculated using the 2−∆∆Ct , where ∆Ct = Ct target gene − Ct Gapdh
and ∆∆Ct = ∆Ct treated condition − ∆Ct untreated condition .
2.7. Protein Extraction
2.7.1. Whole Cell Extracts (WCE)
The whole cell protein extraction from HTR-8 sv/neo cells or placental tissues was prepared
using radio-immunoprecipitation assay (RIPA) lysis as described [24]. Briefly, the cells or tissues were
lysed or homogenized in RIPA buffer containing protease inhibitor cocktail at 4 ◦ C. The lysates were
sonicated for 5 s using vibra-cell ultrasonic processor (Sonics, Newtown, CT, USA) and centrifuged at
15,000× g for 25 min at 4 ◦ C. The supernatant collected is the WCE.
2.7.2. Cytosolic and Nuclear Extraction
Cytosolic and nuclear fractions from placental tissues were prepared as previously described [53].
One hundred mg of placental tissue was minced, and then homogenized on ice in STM buffer [250 mM
sucrose, 50 mM Tris–HCl (pH 7.4), 5 mM MgCl2] which contained protease and phosphatase inhibitor
cocktails. Homogenate was incubated on ice (30 min), vortexed twice at maximum speed (15 s)
and centrifuged at 800× g for 15 min. The supernatant (S0) and pellet (P0) was used for cytosolic
and nuclear fractions, respectively. S0 was spun at 800× g for 10 min and the resultant supernatant
was spun at 11,000× g for 10 min. The collected supernatant containing cytosol and the microsomal
fraction was then acetone precipitated at −20 ◦ C for 2 h followed by centrifugation at 12,000× g for
5 min and the cytosolic pellet was resuspended in STM buffer. The pellet from the first step (P0)
was resuspended in STM buffer, vortexed, spun twice at 500× g for 15 min and 1000× g for 15 min,
and resuspended in NET buffer [20 mM HEPES (pH 7.9), 1.5 mM MgCl2 , 0.5 M NaCl, 0.2 mM EDTA,
20% glycerol, 1% Triton-X-100, protease and phosphatase inhibitors]. This lysate was sonicated for
15 sec at 30% amplitude and centrifuged at 9000× g for 30 min at 4 ◦ C. The supernatant was the final
“nuclear fraction”. The cytosolic and nuclear extracts from HTR8/sv neo cells was prepared using a
commercially available NE-PER Nuclear and Cytoplasmic Extraction kit (Thermoscientific, Rockford,
IL, USA), respectively. The purity of cytosolic and nuclear fraction was determined by the expression
of GAPDH and LAMIN-B1 respectively using immunoblotting.

Biomolecules 2019, 9, 669

6 of 19

2.8. Immunoblotting
Equal amounts of protein lysates were loaded on either NuPAGE 4%–12% Bis-Tris or 12% SDS
gel and subjected to electrophoresis. The separated proteins were electro-transferred onto a PVDF
membrane, rinsed in PBST, and non-specific binding was blocked with 5% non-fat dry milk powder
in PBST for 1 h. Membranes were washed once in PBST for 3 min and probed with either one of the
following primary antibodies against NRF2, PCNA, p21, CYCLIN-D1, KEAP1, LAMIN-B1, TUBULIN,
H3, ACTIN, or GAPDH in PBST for 3 h or overnight at 4 ◦ C as previously described [51,52] and
subsequently washed with PBST three times. Later, the membranes were incubated with either
anti-rabbit IgG or anti-mouse IgG-HRP secondary antibody conjugated with horseradish peroxidase
in PBST (1:1000 or 1:5,000) for 1 h at room temperature. Washed blots (5 times × 5 min each) were
then subjected to ECL-chemiluminescence detection of protein bands. The immunoreactive signals
detected were captured onto an autoradiography film and scanned using Adobe Photoshop CS2 (v9.0,
Mountain View, CA, USA). The intensity of target proteins was quantified using NIH Image J (Version
1.51K, Wayne Rasband, Bethesda, MD, USA) and normalized to either GAPDH or TUBULIN or ACTIN
or LAMIN-B1 or H3 band intensity.
2.9. Reactive Oxygen Species Detection With DCF-DA Using Fluorimetry
DCF-DA staining was used for ROS detection with subsequent fluorimetry analysis [54]. Following
the experiment, DCF-DA reagent (final concentration 25 µM/mL) was added to the cells and incubated
in dark (37 ◦ C) for 30 min in a 5% CO2 humidified incubator. Subsequently, cells were washed once,
phenol red-free RPMI media added to replace the solution, fluorescence was measured immediately
using GloMax Multidetection System (Promega, Madison, WI, USA). The excitation and emission
were at 490 nm and 510–570 nm, respectively. Following the fluorescence measurement, the cells were
trypsinized and resuspended in regular cell growth media and the viability was counted. The data
was expressed the percentage changes in the ratio of DCF-DA fluorescence to 1 × 106 living cells in the
treated condition, after normalizing to untreated control cells (100% fluorescence/cell number).
2.10. MTT Assay
Cell viability was assessed using MTT assay. After completion of the experiment, followed by a
gentle phenol red-free RPMI-1640 media wash, MTT at a final concentration of 0.5 mg/mL the cells were
added and incubated at 37 ◦ C for 2 h. The viable cells’ generated purple absorbance was recorded at
560 nm with 750 nm as reference wavelength using GloMax Multidetection System (Promega, Madison,
WI, USA). The corrected absorbance values (560–750 nm) were expressed as the percentage of viable
cells relative to that of untreated controls.
2.11. Statistical Analysis
Data are presented as mean ± S.E.M. When experiments involved more than two groups, one-way
ANOVA followed by Student–Newman–Keuls post-hoc analysis was used to analyze the statistical
differences. For experiments involving only two groups, Student’s t-test was used. The analysis was
carried out using GraphPad Prism software (Version 5.02, San Diego, CA, USA). A p value less than
0.05 (< 0.05) was considered statistically significant.
3. Results
3.1. Prenatal IEV Exposure Did Not Alter the Placental and Body Weight
Previously, others and we have demonstrated that maternal ethanol exposure impairs placentation,
growth, and placental function [10,13,29,55]. We initiated studies to address the effect of ethanol in vivo
during second trimester equivalent in humans, which is an active phase of placental as well as fetal CNS
development [46–48]. The chronic intermittent exposure (IEV) of alcohol was performed using vapor
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thatofserves
as one
of the
of
in the study
groups
(Figure
2B). The
placental
(Figure
2C) and
diameter
(C vs.
E, majorshape
axis:
placental
growth
also
remained
unchanged
inshape
the study
groups
(Figure
2B). The
placental
10.89
± 0.09
vs 10.88
± 0.08;
0.08 ±vs0.09
10.15
0.04)±(Figure
2D) also
not± change
(Figure
2C) and
diameter
(Cminor
vs. E, axis:
major10.01
axis:±10.89
vs ±10.88
0.08; minor
axis:did
10.01
0.08 vs
significantly
in response
to E.did not change significantly in response to E.
10.15
± 0.04) (Figure
2D) also

intrauterine
alcohol
exposure
on gross
and placental
changes. Pregnant
Figure 2.2. Effect
Effectofof
intrauterine
alcohol
exposure
on body
gross weight
body weight
and placental
changes.
rats
(Sprague-Dawley)
from
gestational
day
11
(GD
11)
to
GD20
were
subjected
to
6h
ON/18h
Pregnant rats (Sprague-Dawley) from gestational day 11 (GD 11) to GD20 were subjected toOFF
6h
everydayOFF
exposure
of Eexposure
with a drip
ofa9drip
or air
(Control)
by(Control)
vapor chamber.
(A)
The gross
ON/18h
everyday
of Erate
with
rate
of 9 or air
by vapor
chamber.
(A)body
The
weight
changes
of the
animals
everyday
exposure
of air
(Control—C)
and ethanol (E)
exposure;
gross body
weight
changes
of after
the animals
after
everyday
exposure
of air (Control—C)
and
ethanol
(B)
at GD20, a(B)
3 h-exposure
used before
placenta
excised, was
trimmed
off the
membranes,
(E) exposure;
at GD20, a 3was
h-exposure
wasthe
used
before was
the placenta
excised,
trimmed
off the
washed
serially
in
HBSS
and
PBS
and
the
dry
weight
recorded
(total
n
=
35
in
C;
n
=
28
in
E
from
3
membranes, washed serially in HBSS and PBS and the dry weight recorded (total = 35 C; n = 28
different
(C) representative
placentas from
a litter tofrom
show
the size
(total the
n = size
35 in(total
C; n =
inin
E
in
E fromlitters);
3 different
litters); (C) representative
placentas
a litter
to show
n 28
= 35
from
different
litters);
(D); end-to-end
placental
diameter
in millimeter
n = 35 in(total
C; n =n 28
inin
E
C;
n =328
in E from
3 different
litters); (D);
end-to-end
placental
diameter(total
in millimeter
= 35
from
litters).
Values represent
the mean
± SEM. ns—not
significant
vs. ethanol.
C;
n =3 different
28 in E from
3 different
litters). Values
represent
the mean
± SEM. ns—not
significant vs.

ethanol.

3.2. In Utero Ethanol Exposure Reduces Nuclear NRF2 Levels
Prior
studies
have
illustrated
thatNuclear
a maternal
two-day
3.2. In
Utero
Ethanol
Exposure
Reduces
NRF2
Levels E binge model elicits a redox imbalance and
oxidative damage to the fetal brain which causes enhanced apoptotic death of fetal cerebral cortical
Prior studies have illustrated that a maternal two-day E binge model elicits a redox imbalance
neurons. This occurs concomitantly with an upregulation of nuclear factor erythroid 2-related factor 2
and oxidative damage to the fetal brain which causes enhanced apoptotic death of fetal cerebral
(NRF2), which provides an important albeit incomplete protection from these events [20]. Since ethanol
cortical neurons. This occurs concomitantly with an upregulation of nuclear factor erythroid
can also elicit oxidative damage in the placenta [13,29,55] and activation of NRF2 has been correlated
2-related factor 2 (NRF2), which provides an important albeit incomplete protection from these
with translocation of this protein into the nucleus, we first tested the nuclear levels of NRF2. In contrast
events [20]. Since ethanol can also elicit oxidative damage in the placenta [13,29,55] and activation of
to the fetal cerebral cortex setting, prenatal E exposure significantly decreased the nuclear levels of
NRF2 has been correlated with translocation of this protein into the nucleus, we first tested the
NRF2 (transcriptionally active) by 61% in the placenta (p < 0.05; Figure 3A,B). This was associated with
nuclear levels of NRF2. In contrast to the fetal cerebral cortex setting, prenatal E exposure
an anti-parallel increase in the cytosolic retention of NRF2 (p < 0.05; Figure 3C,D). Keap1, an inhibitor
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significantly decreased the nuclear levels of NRF2 (transcriptionally active) by 61% in the placenta (p
< 0.05; Figure 3A,B). This was associated with an anti-parallel increase in the cytosolic retention of
NRF2
(p < 0.05;regulator
Figure 3C,D).
Keap1,
inhibitorboth
and negative
regulator
ofnucleus
NRF2 that
both
and negative
of NRF2
thatanmediates
translocation
to the
andmediates
export from
translocation
to the nucleus
and export
from the(pnuclear
remained
unchanged
(p <
the nuclear compartment,
remained
unchanged
< 0.05; compartment,
Figure 3E,F). These
results
indicate that
0.05;
FigureE3E,F).
Thesereduces
results nuclear
indicatelevels
that gestational
exposure
reduces nuclear
of NRF2
gestational
exposure
of NRF2 asEwell
its translocation
to thelevels
nucleus
from
as
well its
translocation
to the nucleus manner.
from cytosol likely in a Keap1-independent manner.
cytosol
likely
in a Keap1-independent

Figure 3. Effect
Effect of intrauterine alcohol exposure on NRF2 and
and KEAP1
KEAP1 protein
protein expression.
expression. (A) A
immunoblot image detecting
detecting placental
placental NRF2
NRF2 and LAMIN B1 protein expression in
representative immunoblot
nuclear fraction (upper panel) and its quantification (bottom panel) from air (C) and IEV (E) exposed
rats (hours)
12; n
n == 44 each
each from
from 33 different
different litters);
rats
(hours) (total
(total n
n=
= 12;
litters); (B)
(B) immunodetection
immunodetection of
of placental
placental NRF2
NRF2
and
GAPDH
protein
in
the
cytosol
of
air
(C)
and
IEV
(E)
exposed
pregnant
rats
measured
by Western
and GAPDH protein in the cytosol of air (C) and IEV (E) exposed pregnant rats measured
by
blotting (upper
panel)
and the
corresponding
quantification of
NRF2 proteinoflevels
normalized
to the
Western
blotting
(upper
panel)
and the corresponding
quantification
NRF2
protein levels
reference protein,
(total
n = 12;panel)
n = 4 each
3 different
litters);
Western
normalized
to theGAPDH
reference(bottom
protein,panel)
GAPDH
(bottom
(totalfrom
n = 12;
n = 4 each
from(C)
3 different
blot
image
of
KEAP1
and
LAMIN
B1
protein
in
placenta
obtained
from
air
(C)
or
vapor
based
litters); (C) Western blot image of KEAP1 and LAMIN B1 protein in placenta obtained from airethanol
(C) or
(IEV)-exposed
pregnant
dams (upper
panel) dams
and the
image
densities
of KEAP1
relative to
vapor based ethanol
(IEV)-exposed
pregnant
(upper
panel)
and the
image densities
ofLAMIN
KEAP1
B1 (bottom
= 12; n panel)
= 4 each
fromn3 different
litters);
(D)from
representative
relative
to panel)
LAMIN(total
B1 n
(bottom
(total
= 12; n =4
each
3 differentimmunoblots
litters); (D)
demonstrating the
expression of
KEAP1 protein,
with
GAPDH as
loadingprotein,
control inwith
placenta
of control
representative
immunoblots
demonstrating
the
expression
of aKEAP1
GAPDH
as a
and
intrauterine
alcohol-exposed
pregnant
rats
(upper
panel)
and
the
quantification
of
immunoblots
loading control in placenta of control and intrauterine alcohol-exposed pregnant rats (upper panel)
of KEAP1
normalized toofGAPDH
(bottom
represent
the mean(bottom
± SEM.panel).
* p < 0.05
was
and
the quantification
immunoblots
of panel).
KEAP1Values
normalized
to GAPDH
Values
considered
significant
vs
ethanol.
represent the mean ± SEM. * p < 0.05 was considered significant vs ethanol.

3.3. In Utero Ethanol Represses NRF2-Mediated Transcriptional Activation in the Placenta
3.3. In Utero Ethanol Represses NRF2-Mediated Transcriptional Activation in the Placenta
As in utero E decreased the placental nuclear NRF2 levels, we next determined whether this was
As in utero E decreased the placental nuclear NRF2 levels, we next determined whether this
associated with a decrease in some of its well-known downstream target genes expression. Multiplex
was associated with a decrease in some of its well-known downstream target genes expression.
Taqman real-time qRT-PCR analysis for glutamate–cysteine ligase catalytic subunit (Gclc; Figure 4A),
Multiplex Taqman real-time qRT-PCR analysis for glutamate–cysteine ligase catalytic subunit (Gclc;
glutamate–cysteine ligase modifier subunit (Gclm; Figure 4B), glutathione reductase (Gsr; Figure 4C),
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Figure 4A), glutamate–cysteine ligase modifier subunit (Gclm; Figure 4B), glutathione reductase
(Gsr;
Figure 4C), (Ho-1;
hemeoxygenase
Figure 4D),
and NAD(P)H
quinone1dehydrogenase
1 (Nqo1;
hemeoxygenase
Figure 4D),(Ho-1;
and NAD(P)H
quinone
dehydrogenase
(Nqo1; Figure 4E)
using
Figure
4E) using
differentially
probe
for (FAM
individual
genes
and Gapdh
(VIC
differentially
labeled
probe for labeled
individual
genes
probe)
and (FAM
Gapdh probe)
(VIC probe)
showed
a
probe)
showed
a
significant
decrease
in
their
transcript
expression
(p
<
0.05).
Interestingly,
the
significant decrease in their transcript expression (p < 0.05). Interestingly, the mRNA expression of
mRNA
expression factor
of NF-E2
p45-related
(Nfe2l2
Nrf2)togene,
which
is known to undergo
NF-E2 p45-related
2 (Nfe2l2
or Nrf2)factor
gene,2which
is or
known
undergo
self-regulation
was also
self-regulation
was alsorepressed
found to(pbe
significantly
repressed
(p <illustrate
0.05) (Figure
data
found to be significantly
< 0.05)
(Figure 4F).
These data
that in 4F).
uteroThese
E-induced
illustrate
that
in
utero
E-induced
NRF2
reduction
appears
to
functionally
reflect
an
impairment
of
NRF2 reduction appears to functionally reflect an impairment of transcriptional activation of its
transcriptional
target genes. activation of its target genes.

Figure 4.
Effect of
of in
in utero
utero alcohol
exposure on
on the
Figure
4. Effect
alcohol exposure
the mRNA
mRNA expression
expression of
of Nfe2l2
Nfe2l2 and
and NRF2
NRF2 target
target
genes’ in
the placenta.
placenta. Pregnant
Pregnant SD
SD rats
rats were
were exposed
exposed to
air (C)
(C) or
or IEV
IEV (E)
(E) for
for the
the periods
periods indicated
indicated in
in
genes’
in the
to air
Figure
1
and
real-time
qRT-PCR
analysis
for
NRF2
target
genes’
was
performed.
(A)
The
fold
change
Figure 1 and real-time qRT-PCR analysis for NRF2 target genes’ was performed. (A) The fold change
mRNA expression
expression of
of Gclc;
Gclc; (B)
(B) Gclm;
Gclm; (C)
(C) Gsr;
Gsr; (D)
(D) Ho-1;
(E) Nqo1;
and (F)
(F) Nfe2l2
by
mRNA
Ho-1; (E)
Nqo1; and
Nfe2l2 was
was determined
determined by
normalizing
with
the
expression
of
a
housekeeping
gene,
Gapdh.
A
total
of
12
samples
with
4
each
normalizing with the expression of a housekeeping gene, Gapdh. A total of 12 samples with 4 each
from 33 different
from
different litters
litters were
were examined.
examined. Values
Values represent
represent the
the mean
mean ±± SEM.
SEM. ** pp <
< 0.05
0.05 was
was considered
considered
significant
versus
ethanol.
significant versus ethanol.

3.4. In Vitro E Impairs Nuclear Nrf2 Levels and its Transactivation Function in Human Trophoblasts
3.4. In Vitro E Impairs Nuclear Nrf2 Levels and its Transactivation Function in Human Trophoblasts
Having shown that gestational E impairs the NRF2 nuclear localization and its transactivation
Having shown that gestational E impairs the NRF2 nuclear localization and its transactivation
function in utero, we next tested whether there is an alteration in NRF2 and its activity in vitro
function in utero, we next tested whether there is an alteration in NRF2 and its activity in vitro
following E exposure in human HTR8/sv neo trophoblast cells. Immunoblotting analyses indicated
following E exposure in human HTR8/sv neo trophoblast cells. Immunoblotting analyses indicated
that 24 h did not significantly alter nuclear NRF2 content, while a significant diminution is seen at
that 24 h did not significantly alter nuclear NRF2 content, while a significant diminution is seen at 48
48 h by about 70% at 48 h (p < 0.05; Figure 5A,B). Since we did not observe any change in nuclear
h by about 70% at 48 h (p < 0.05; Figure 5A,B). Since we did not observe any change in nuclear NRF2
NRF2 at 24 h, we measured the basal transactivation function of NRF2 in terms of 4x ARE-driven
at 24 h, we measured the basal transactivation function of NRF2 in terms of 4x ARE-driven luciferase
luciferase reporter activity. As expected, we observed a parallel reduction in 4x ARE-luciferase activity
reporter activity. As expected, we observed a parallel reduction in 4x ARE-luciferase activity by
by about 60% indicating a functional correlation (p < 0.05; Figure 5C). Since NRF2 is a stress-inducible
about 60% indicating a functional correlation (p < 0.05; Figure 5C). Since NRF2 is a stress-inducible
transcription factor, we induced NRF2 activity by tBHQ, and interestingly, found that E was able to
transcription factor, we induced NRF2 activity by tBHQ, and interestingly, found that E was able to
reduce the inducible NRF2-dependent transactivation significantly (p < 0.05; Figure 5D). However,
reduce the inducible NRF2-dependent transactivation significantly (p < 0.05; Figure 5D). However,
unlike basal condition, E was able to reduce the inducible ARE reporter activity only by approximately
unlike basal condition, E was able to reduce the inducible ARE reporter activity only by
20% (p < 0.05; Lane 3 vs. 4; Figure 5D). These results support our hypothesis that alcohol can perturb
approximately 20% (p < 0.05; Lane 3 vs. 4; Figure 5D). These results support our hypothesis that
NRF2 and its function under physiological (basal) and inducible (overexpression) setting in human
alcohol can perturb NRF2 and its function under physiological (basal) and inducible
HTR8/sv neo trophoblasts.
(overexpression) setting in human HTR8/sv neo trophoblasts.
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ethanol exposure
exposure on
on the
the nuclear
nuclear levels
levels of
of NRF2
NRF2 and
and its
its transactivation
transactivation
Figure 5. Effect
Effect of in vitro ethanol
ability. HTR8/sv neo trophoblasts were treated with
with E (4
(4 mg/mL)
mg/mL) as
as indicated
indicated in
in Section
Section 2.2.
2.2. (A) The
ability.
protein levels
levelsof
ofNRF2
NRF2ininthe
thenucleus
nucleus
were
determined
immunoblot
analyses
equal
loading
protein
were
determined
by by
immunoblot
analyses
andand
equal
loading
was
was assessed
by anti-H3;
(B)densitometric
the densitometric
scanning
analysis
of NRF2
H3 band
intensities
assessed
by anti-H3;
(B) the
scanning
analysis
ratioratio
of NRF2
to H3toband
intensities
was
performed
using using
NIH ImageJ
analysis;
(C) cells(C)
were
transfected
with luciferase
was performed
NIH ImageJ
analysis;
cells
were transfected
with construct
luciferasecontaining
construct
NRF2-binding
ARE sequences
4 tandem
along
with along
pRL-renilla
construct asconstruct
detailed as
in
containing NRF2-binding
ARE with
sequences
withrepeats
4 tandem
repeats
with pRL-renilla
Section
NRF2 transactivation
was determined
terms of luciferase
renilla and to
detailed2.4.
in Section
2.4. NRF2 transactivation
was in
determined
in terms normalized
of luciferasetonormalized
protein
(n = to
12);protein
(D) cells
transfected
as inand
(C) processed
but for t-BHQ
pretreatment
24 h
renilla and
(nwere
= 12);
(D) cells and
wereprocessed
transfected
as in
(C) but forfor
t-BHQ
(n
= 12). Values
± represent
SEM. * p <the
0.05
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pretreatment
forrepresent
24 h (n = the
12).mean
Values
mean
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3.5. In Vitro E Inhibits Cell Viability in Association with Dysregulation of PCNA, Cyclin D1, and p21 in
Human Trophoblasts
3.5. In Vitro E Inhibits Cell Viability in Association with Dysregulation of PCNA, Cyclin D1, and p21 in
Having
shown the dysregulation of NRF2 by E exposure, we next addressed the functional or
Human
Trophoblasts
phenotypic relevance of E-induced NRF2 loss. To this end, we assessed the growth of trophoblasts
Having shown the dysregulation of NRF2 by E exposure, we next addressed the functional or
by MTT assay. Following E treatment, we observed growth-suppression of human trophoblasts
phenotypic relevance of E-induced NRF2 loss. To this end, we assessed the growth of trophoblasts
by about 50% (p < 0.05; Figure 6A) relative to control at 48 h. This suggests that NRF2 loss has
by MTT assay. Following E treatment, we observed growth-suppression of human trophoblasts by
some association with the growth inhibition. Since E-inhibited NRF2 associated transactivation of
about 50% (p < 0.05; Figure 6A) relative to control at 48 h. This suggests that NRF2 loss has some
antioxidant genes, it is reasonable to expect ROS levels to be enhanced. To this end, we measured
association with the growth inhibition. Since E-inhibited NRF2 associated transactivation of
the intracellular ROS level using DCFDA-based fluorescence. The fluorescence intensity of DCF-DA
antioxidant genes, it is reasonable to expect ROS levels to be enhanced. To this end, we measured the
normalized to 1 million living cells was significantly increased in E treated cells by approximately
intracellular ROS level using DCFDA-based fluorescence. The fluorescence intensity of DCF-DA
30% (p < 0.05; Figure 6B) in relation to control cells indicating that the reduced NRF2 in the cells was
normalized to 1 million living cells was significantly increased in E treated cells by approximately
permissive for ROS accumulation. To dig deeper into the mechanism of E-induced cellular growth
30% (p < 0.05; Figure 6B) in relation to control cells indicating that the reduced NRF2 in the cells was
suppression, we next assessed the expression pattern of proliferating cell nuclear antigen (PCNA),
permissive for ROS accumulation. To dig deeper into the mechanism of E-induced cellular growth
since it is one of the critical determinants of growth and proliferation of cells. In line with the cell
suppression, we next assessed the expression pattern of proliferating cell nuclear antigen (PCNA),
growth inhibition data, we found that 48 h E-significantly decreased the protein expression of PCNA
since it is one of the critical determinants of growth and proliferation of cells. In line with the cell
by about 50% (p < 0.05; Figure 6C,D) in human trophoblasts. We next determined the expression of
growth inhibition data, we found that 48 h E-significantly decreased the protein expression of PCNA
CYCLIN-D1, a key cell cycle protein required for the progression of the cell cycle from G1 to S that
by about 50% (p < 0.05; Figure 6C,D) in human trophoblasts. We next determined the expression of
mediates growth. E-exposure significantly blunted the expression of CYCLIN D1 protein by 65%
CYCLIN-D1, a key cell cycle protein required for the progression of the cell cycle from G1 to S that
(p < 0.05; Figure 6E,F). Since p21 can simultaneously bind to the DNA polymerase delta processivity
mediates growth. E-exposure significantly blunted the expression of CYCLIN D1 protein by 65% (p <
factor, PCNA, and CYCLIN-D1 and inhibit their growth-promoting function, we posited p21 levels
0.05; Figure 6E,F). Since p21 can simultaneously bind to the DNA polymerase delta processivity
may go up in response to E. Consistent with this, we found that E treatment significantly enhanced the
factor, PCNA, and CYCLIN-D1 and inhibit their growth-promoting function, we posited p21 levels
may go up in response to E. Consistent with this, we found that E treatment significantly enhanced
the p21 levels by three-fold when compared to control cells (p < 0.05; Figure 6G,H). This is an
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indication
that
p21 may
collaborate
PCNA
and
to repress
the
of
p21
levels by
three-fold
when
comparedwith
to control
cells
(p <CYCLIN-D1
0.05; Figure 6G,H).
This is
an growth
indication
trophoblasts
E.
that
p21 may upon
collaborate
with PCNA and CYCLIN-D1 to repress the growth of trophoblasts upon E.

Figure 6.6. InInvitro
effects
on the
and expression
of growth-related
proteins proteins
in HTR8/sv
vitroethanol
ethanol
effects
on viability
the viability
and expression
of growth-related
in
neo
trophoblasts.
(A) E-treatment
at a concentration
of 4 mg/mLof
of 4E mg/mL
was done
48 h.done
The for
trophoblasts
HTR8/sv
neo trophoblasts.
(A) E-treatment
at a concentration
of for
E was
48 h. The
cell
viability cell
wasviability
measured
using
MTT assay
shown
percentage
cells; viable
(B) effect
of(B)
48
trophoblasts
was
measured
usingand
MTT
assay as
and
shown as viable
percentage
cells;
h
E onofintracellular
ROS level measured
fluorometry
after DCF-DA
treatment.
results The
are
effect
48 h E on intracellular
ROS levelby
measured
by fluorometry
after
DCF-DA The
treatment.
expressed
percentage
fluorescence
units (FLU)units
per the
cell per
number;
(C)number;
equal amounts
of amounts
proteins
results are as
expressed
as percentage
fluorescence
(FLU)
the cell
(C) equal
from
E-treated
trophoblasts
at the indicated
time
points were
resolved
by resolved
SDS-PAGE
subjected
to
of proteins
from
E-treated trophoblasts
at the
indicated
time points
were
byand
SDS-PAGE
and
immunoblot
directed
against
PCNA
and
a
representative
blots
are
shown;
(D)
graphical
representation
subjected to immunoblot directed against PCNA and a representative blots are shown; (D) graphical
of
the quantification
PCNA normalized
to TUBULIN
expression;
(E) representative
for
representation
of theofquantification
of PCNA
normalized
to TUBULIN
expression; (E)immunoblot
representative
CYLCIN-D1
expressionprotein
following
E exposure;
(F) semi-quantitative
of CYCLIN-D1
and
immunoblotprotein
for CYLCIN-D1
expression
following
E exposure; (F)analysis
semi-quantitative
analysis
TUBULIN
ratios of
experiments
(E);of(G)
immunoblotfrom
analysis
protein expression
of CYCLIN-D1
and
TUBULINfrom
ratios
experiments
(E); for
(G)p21
immunoblot
analysisfollowing
for p21
48
h E exposure
of trophoblasts
served as loading
control;blots
(H) served
the densitometric
protein
expression
following 48 and
h E GAPDH
exposureblots
of trophoblasts
and GAPDH
as loading
quantification
of
p21
normalized
to
GAPDH
levels.
Values
represent
the
mean
±
SEM from
n = 6.
control; (H) the densitometric quantification of p21 normalized to GAPDH levels. Values
represent
*the
p <mean
0.05 was
considered
ethanol and
ns indicates
not significant.
± SEM
from n =significant
6. * p < 0.05versus
was considered
significant
versus
ethanol and ns indicates not

significant.

3.6. In Utero E Affects the Expression of Growth Perpetuating Factors in Placenta
Next,
weE determined
whether the
E-induced
in vitro expression
changes in growth-related factors
3.6. In
Utero
Affects the Expression
of Growth
Perpetuating
Factors in Placenta
observed in human trophoblasts are replicated in placentas from in utero E-exposed animals. Akin to
Next, we determined whether the E-induced in vitro expression changes in growth-related
factors observed in human trophoblasts are replicated in placentas from in utero E-exposed animals.
Akin to the in vitro changes, maternal E exposure significantly abolished the expression of PCNA by
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the in vitro changes, maternal E exposure significantly abolished the expression of PCNA by about
about(p30%
(p <Figure
0.05; 7A,B)
Figureand
7A,B)
and CYCLIN-D1
about
< 0.05;7C,D)
Figure
in the
30%
< 0.05;
CYCLIN-D1
by aboutby55%
(p <55%
0.05;(pFigure
in 7C,D)
the placenta.
placenta.
Since
an
increase
in
p21
is
correlated
to
growth
arrest,
we
then
analyzed
p21
expression
Since an increase in p21 is correlated to growth arrest, we then analyzed p21 expression under the same
under the same
conditions.
In contrast
to PCNA and
CYCLIN-D1
expression,
p21 protein
expression
conditions.
In contrast
to PCNA
and CYCLIN-D1
expression,
p21 protein
expression
was significantly
was significantly
upregulated
by Figure
~2.1-fold
(p These
< 0.05;results
Figure
7E,F). These
results illustrate
that
upregulated
by ~2.1-fold
(p < 0.05;
7E,F).
illustrate
that gestational
E can impair
gestational
E
can
impair
the
growth-promoting
PCNA/CYCLIN-D1/p21
network.
the growth-promoting PCNA/CYCLIN-D1/p21 network.

Figure 7. Effects
Effectsof
ofintrauterine
intrauterineIEV
IEVexposure
exposureonon
protein
expression
of growth
modulators
in
thethe
protein
expression
of growth
modulators
in the
the
placenta.
The exposure
IEV exposure
was performed
as in Figure
1. (A) Representative
immunoblots
placenta.
The IEV
was performed
as in Figure
1. (A) Representative
immunoblots
and (B)
and
(B) densitometric
summary
for PCNA
in the
placenta;
CYCLIN-D1protein
protein expression
expression by
densitometric
summary
for PCNA
in the
placenta;
(C)(C)
CYCLIN-D1
immunoblotting and (D) its densitometric quantification in the placental tissue; (E) determination of
placental
For
each
measurement,
a total
of
placental p21
p21 protein
proteinexpression
expressionand
and(F)
(F)itsitsquantification
quantificationsummary.
summary.
For
each
measurement,
a total
12
placentas
with
4
each
from
3
different
litters
were
used.
Values
represent
the
mean
±
SEM.
*
p
<
0.05
of 12 placentas with 4 each from 3 different litters were used. Values represent the mean ± SEM. * p <
was
significant
versus
ethanol.
0.05 considered
was considered
significant
versus
ethanol.

3.7. Genetic Overexpression of Nrf2 Partially Ameliorates the E-Induced Growth Suppression Phenotype
3.7. Genetic Overexpression of Nrf2 Partially Ameliorates the E-Induced Growth Suppression Phenotype
Finally, to confirm whether the gain of function of NRF2 rescues E-induced growth inhibition of
Finally, to confirm whether the gain of function of NRF2 rescues E-induced growth inhibition of
trophoblasts, we performed exogenous overexpression of Nrf2 using a cDNA construct. The efficiency
trophoblasts, we performed exogenous overexpression of Nrf2 using a cDNA construct. The
of cDNA-mediated Nrf2 overexpression was confirmed by a significant increase in the levels of NRF2
efficiency of cDNA-mediated Nrf2 overexpression was confirmed by a significant increase in the
protein in WCE (p < 0.05; Figure 8A,B). Having verified the expression of NRF2, we next assessed the
levels of NRF2 protein in WCE (p < 0.05; Figure 8A,B). Having verified the expression of NRF2, we
effect of E-induced NRF2-dependent transactivation repression with and without Nrf2 overexpression.
next assessed the effect of E-induced NRF2-dependent transactivation repression with and without
Empty vector-transfected cells, when exposed to E, showed significant repression of 4x ARE reporter
Nrf2 overexpression. Empty vector-transfected cells, when exposed to E, showed significant
activity by about 58% (p < 0.05; Lane 1 vs. 2, Figure 8C). However, overexpression of the Nrf2
repression of 4x ARE reporter activity by about 58% (p < 0.05; Lane 1 vs. 2, Figure 8C). However,
construct led to significant improvement of E-induced loss of transactivation ability (Figure 8C).
overexpression of the Nrf2 construct led to significant improvement of E-induced loss of
In particular, E was able to reduce the inducible ARE reporter activity only by 21% (p < 0.05; Lane
transactivation ability (Figure 8C). In particular, E was able to reduce the inducible ARE reporter
3 vs. 4; Figure 8C). In parallel, E repressed the percentage of viable cells significantly by about 55%
activity only by 21% (p < 0.05; Lane 3 vs. 4; Figure 8C). In parallel, E repressed the percentage of
in the empty vector-transfected cells (p < 0.05; Lane 1 vs. 2, Figure 8D). However, when Nrf2 was
viable cells significantly by about 55% in the empty vector-transfected cells (p < 0.05; Lane 1 vs. 2,
overexpressed the survival percentage was promoted and E-induced decrease in survival was only
Figure 8D). However, when Nrf2 was overexpressed the survival percentage was promoted and
around 25% (p < 0.05; Lane 3 vs. 4, Figure 8D). This indicates that Nrf2 overexpression appears to
E-induced decrease in survival was only around 25% (p < 0.05; Lane 3 vs. 4, Figure 8D). This
indicates that Nrf2 overexpression appears to partially prevent the E-induced growth repression of
trophoblasts. Further, E-induced PCNA silencing was significantly restored upon ectopic
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partially prevent the E-induced growth repression of trophoblasts. Further, E-induced PCNA silencing
was
significantlyofrestored
ectopic
overexpression
of Nrf2
(p <overexpression
0.05; Figure 8E,F).
Conversely, Nrf2
overexpression
Nrf2 (pupon
< 0.05;
Figure
8E,F). Conversely,
Nrf2
in trophoblast
cells
overexpression
in trophoblast
cells elicited
a normalization
of E-induced
levels
towards
control
elicited
a normalization
of E-induced
p21 levels
towards control
(p < 0.05;p21
Figure
8G,H).
These
data
(p
<
0.05;
Figure
8G,H).
These
data
show
that
restoration
of
NRF2
signaling
could
play
a
pivotal
role
in
show that restoration of NRF2 signaling could play a pivotal role in regulating the E-induced
regulating
the
E-induced
reduction
in
cell
growth,
at
least,
partially.
reduction in cell growth, at least, partially.
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E-induced
dysregulation
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4. Discussion
An intact placenta and functional placental cells are vital for normal fetal growth and survival.
Our study demonstrates that maternal IEV stress elicits impairment in the master redox regulator,
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4. Discussion
An intact placenta and functional placental cells are vital for normal fetal growth and survival.
Our study demonstrates that maternal IEV stress elicits impairment in the master redox regulator, NRF2
in association with modulation of growth-related parameters in rat placenta and human trophoblasts
exposed to E. The principal findings of the current study include: (1) Placentas from pregnant rats
exposed to IEV displayed a blunted NRF2 and its transactivation function, which was also captured in
the in vitro exposure of E to HTR8/sv neo, a human trophoblast line; (2) E-induced dysregulation of
NRF2 signaling is associated with a reduction in the expression of growth-promoting factors, PCNA
and CYCLIN-D1 both in vivo and in vitro; (3) These changes were accompanied by upregulation of
cyclin inhibitory protein p21; and (4) An ectopic overexpression of Nrf2 rendered partial recovery
of E-induced dysregulation of growth-promoting factors and cell survival of human trophoblasts.
Together, these results illustrate that downstream of E-related NRF2 regression, prenatal maternal IEV
stress aberrantly regulates the growth effectors such as PCNA, CYCLIN-D1, and p21.
It is to be noted that many of the signaling changes assessed in the in vitro trophoblasts exposed
to E in the present study were replicated in vivo in rat placenta tissue. First, this is in keeping
with the data that both in vitro and in utero E exposure elicited a nuclear NRF2 diminution and its
transactivation ability in trophoblasts and placental tissue, respectively (Figures 2 and 3). This is a
relevant finding because, although in utero E has been previously shown to impair redox homeostasis
in which NRF2 was enhanced as an adaptive response in non-placental setting to at least partially
counter the injury, this is the first demonstration that E-induces NRF2 downregulation in placenta
in vivo following the maternal IEV exposure and also to trophoblasts in vitro. The disruption of redox
balance with a retarded NRF2 function has been shown to cause placental dysfunction in several
preclinical and in vitro E-mimicking oxidative stress inducing conditions such as cigarette smoke,
fructose, and 5-α-dihydrotestosterone and insulin resistance [56–58]. Further, in a non-placental setting,
we have previously found that persistent and/or severe oxidative stress can dampen NRF2 signaling via
microRNAs (miR) such as miR-144, miR-142-5p, miR-153, and miR27a [51,52]. Another independent
study identified miR142 and miR144 as pregnancy-associated miRs that were found to be involved in
congenital malformations [59].
To further understand the impact of NRF2 impairment on the phenotypic outcome, we assessed the
proliferation of trophoblasts in vitro as well as the gross placental and body weight as characteristics of
growth. Typically, in the alcohol-vapor exposure model, during the first week or less, issues associated
with a reduced rate of body weight gain in E-exposed animals is plausible. However, this has been
circumvented by coordinating our alcohol exposure during the light phase of the light/dark cycle
where animals are less active and less likely to consume food. This ensures that changes in food
and water consumption pattern that normally occurs during the active (dark) phase do not influence
our experimental condition. Data from this study indicated that in vitro E exposure while exerting
growth suppression responses in human trophoblasts (Figure 6A,B) in tandem with a blunted NRF2
signaling, the in vivo IEV exposure had no significant effect on gross body or placental weight change
(Figure 2). Consistent with our results, a previous finding in pregnant mice has demonstrated that
alcohol exposure through vapor chamber for 4 h daily during GD5-20 displayed no discernible changes
in the fetus weight and placenta weight [50]. However, another study has illustrated significant
repression of placental growth, albeit, in a continuous liquid diet-based alcohol exposure model from
GD6-18 in Long Evans rats [12]. The differences connected with the in vitro and in vivo data could be
easily due to complex environmental differences in trophoblast milieu with effects of E on trophoblasts
in vitro being direct while in the in vivo niche, such impacts could reflect multiple maternal-related
factors. These could be interactions of other cell types (from the maternal system) such as immune
cells [60] or low oxygen environment [61,62], which could exert completely divergent effects to shape
the trophoblasts’ biological property (invasiveness) and thus, the overall growth trajectory of the fetus.
In addition, the discrepancies seen among these reports with respect to in vivo growth responses
could be due to the impact of the length (GD6-18 vs GD11-20), exposure regimen (continuous vs.

Biomolecules 2019, 9, 669

15 of 19

intermittent), and mode (liquid or vapor chamber) of exposure of E. To unequivocally demonstrate the
role of NRF2 dysregulation on in utero E on growth phenotype, it will thus be necessary to test this on
NRF2 knockouts.
PCNA and CYCLIN-D1 govern the cellular proliferation and growth by coordinately regulating
the cell cycle with DNA replication, where PCNA forms a DNA sliding clamp for replicative DNA
polymerase and regulates DNA synthesis. CYCLIN-D1 regulates the G1/S-phase transition of the
cell cycle [63]. Shown here, the 48 h exposure of human trophoblasts to E in vitro and in utero
in rats resulted in a reduction of PCNA and CYCLIN-D1 expression (Figures 6 and 7). Abridged
PCNA and CYCLIN-D1 levels have been previously shown to impair the placental development in
conditions that are underscored by oxidative stress akin to E [64,65]. While E-induced diminution
of proliferation-associated proteins such as PCNA and CYCLIN-D1 which closely correlated with a
reduction in the proliferative capacity in vitro, this was not reflected in the in utero E exposed rats with
the unchanged placental and body weights (Figure 2). Based on these observations with the current
IEV paradigm, we propose that concerted signal(s) other than PCNA and CYCLIN-D1 driven by spatial
location (local environment) may be required to effect a gross change in the placental and overall
growth. Nevertheless, a priming anti-growth program is established with respect to molecular changes
(PCNA and CYCLIN-D1 levels) in the placenta. Relevantly, a complicated role for PCNA during
the perinatal stage has been reported, where the downregulation of PCNA in mouse ovaries during
primordial follicle formation, has been shown to favor the survival of oocytes [66]. While the current
results do not completely exclude the ability of E to impact the proliferative or replicative strength of
the trophoblast population. Especially in vivo, the complexities of post-translational modifications
such as phosphorylation or ubiquitination and translocation of other key effectors in conjunction
with PCNA and CYCLIN-D1 to modulate trophoblast-specific in vivo proliferative changes are being
evaluated in our laboratory.
Finally, in vitro experiments using human trophoblasts demonstrated that E resulted in abnormal
accumulation of p21, which correlated with proliferation inhibition (Figure 6). The p21 increase could
be attributed to PCNA loss, since, PCNA has been shown to physically interact with and promote
the degradation of p21 to switch on the DNA replication and cell cycle [67]. However, the intriguing
finding is that the augmentation of p21 showed no-correlation with placental or gross body weight
changes (representative of growth) when pregnant rats were challenged with intrauterine IEV exposure
(Figures 2 and 7). It is plausible that in the presence of a teratogen like E, despite high levels of p21,
its localization could be altered due to phosphorylation by protein kinases, which curbs the p210 s
negative cell cycle regulatory function. In particular, phosphorylation of p21 at Thr57 by glycogen
synthase kinase 3β (GSK3β) has been shown to increase its ability to bind to cyclin B1-CDK1 complexes
without inhibiting the complexes or cell-cycle progression, denoting the active growth process [68].
In a brain developmental setting, E has been shown to activate GSK3β [69]. Despite high levels of p21,
its exclusion from the nucleus to cytosol has also been illustrated to favor a pro-growth shift [68]. It is
also reasonable to argue that always anchoring the molecular expression pattern in dose, as well as in
time and phenotypic outcome could be complex, as observed here with a non-linear pattern between
E-elicited molecular changes and growth assessed in terms of body or placental weight. Nevertheless,
our findings could suggest that the inductive molecular and cellular signaling change could occur
well before the onset of defined cellular or biological phenotype. This result is particularly relevant to
the developmental context since it is most often associated with producing patterns rather than traits.
Thus, our results also draw attention to considering clusters of genes that regulate specific functions
together with the cellular context, dose-response relationships, endogenous metabolism, molecular
regulations via phosphorylations and protein-protein interactions.
5. Conclusions
In summary, the present report demonstrates repression of NRF2 in parallel with dysregulation of
a PCNA/CYCLIN-D1/p21 growth-signaling network in E-exposed human trophoblast cells as well as
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in the placenta following second-trimester human equivalent intrauterine exposure to maternal IEV.
While E-induced signaling alterations are functionally reflected in suppressing the proliferative ability
in vitro, the in vivo molecular changes do not appear to grossly reflect on the weight-related growth of
the placenta or the animal, per se. This could reflect compensatory systems active in the presence of
normal maternal nutrition. Also, scientifically important findings here are the E-related dysregulation
of NRF2 and its transactivation function observed both in vivo and in the human trophoblast model
and the ability of the overexpression of NRF2 rendering (but only partial) recovery of the E-induced
dysregulation of growth-promoting factors and cell survival of human trophoblasts (Figure 8).
Given all the molecular changes studied here are similar in both in vitro and in vivo setting,
ethanol by dysregulating the NRF2-based cell stress pathway appears to have developed a primed or
sensitized maladaptive profile that may alter the program of cell fate commitment and contribute to
placental-associated complications.
Author Contributions: Conceptualization, M.N. and L.M.; methodology, M.N., L.M., S.K. and G.I.H.; validation,
S.S., J.M.W. and C.K.; formal analysis, S.S., D.P., M.N. and L.M.; investigation, S.S., D.P., J.M.W., C.K. and X.L.;
resources, G.I.H.; writing—original draft preparation, M.N., L.M., and S.K.; writing—review and editing, M.N.,
L.M., G.I.H. and S.E.B.; supervision, M.N., L.M. and G.I.H.; project administration, M.N. and G.I.H.; funding
acquisition, G.I.H.
Funding: This research was supported by the National Institute of Alcohol Abuse and Alcoholism, (RO1
AA010114) to (G.I.H.), National Institute of Alcohol Abuse and Alcoholism, (RO1 AA027189-01A1), NIH COBRE
1P20GM113126, Nebraska Research Initiative Grant to (S.K.).
Acknowledgments: We thank Roland C. Wolf (Dundee, UK) and Jawed Alam (Alton Ochsner Medical Foundation,
New Orleans, LA) for kindly providing us the 4× ARE Luc plasmid and pEF-Nrf2 cDNA construct, respectively.
Conflicts of Interest: The authors declare no conflict of interest.

References
1.
2.
3.
4.
5.
6.
7.
8.
9.

10.
11.

12.

Burd, J.; Blair, J.; Dropps, K. Prenatal Alcohol Exposure, Blood Alcohol Concentrations and Alcohol
Elimination Rates for the Mother, Fetus and Newborn. J. Perinatol. 2012, 32, 652–659. [CrossRef]
Bailey, B.A.; Sokol, J. Pregnancy and Alcohol Use: Evidence and Recommendations for Prenatal Care. J. Clin.
Gynecol. Obstet. 2008, 51, 436–444. [CrossRef]
Jones, K.L.; Smith, D.L.; Ulleland, C.W.; Streissguth, A.P. Pattern of Malformation in Offspring of Chronic
Alcoholics. Lancet 1973, 2, 999–1001. [CrossRef]
Sulik, K.K. Fetal Alcohol Spectrum Disorder: Pathogenesis and Mechanisms. Handb. Clin. Neurol.
2014, 125, 463–475. [PubMed]
Clarren, S.K.; Smith, D.W. The Fetal Alcohol Syndrome. N. Engl. J. Med. 1978, 298, 1063–1067. [CrossRef]
[PubMed]
Jones, K.L. The Effects of Alcohol on Fetal Development. Birth Defects Res. 2011, 93, 3–11. [CrossRef]
[PubMed]
Henderson, G.I.; Schenker, S. The Effects of Maternal Alcohol Consumption on The Viability and Visceral
Development of The Newborn Rat. Res. Commun. Chem. Pathol. Pharmacol. 1977, 16, 15–32.
Randall, C.L.; Taylor, W.J. Prenatal Ethanol Exposure in Mice: Teratogenic Effects. Teratology 1979, 19, 305–311.
[CrossRef]
Patwardhan, R.V.; Schenker, S.; Henderson, G.I.; Abou-Mourad, N.N.; Hoyumpa, A.M. Short-Term and
Long-Term Ethanol Administration Inhibits the Placental Uptake and Transport of Valine in Rats. J. Lab. Clin.
Med. 1981, 98, 251–262.
Henderson, G.I.; Patwardhan, R.V.; McLeroy, S.; Schenker, S. Inhibition of Placental Amino Acid Uptake in
Rats Following Acute and Chronic Ethanol Exposure. Alcohol. Clin. Exp. Res. 1982, 6, 495–505. [CrossRef]
Aliyu, M.H.; Lynch, O.; Nana, P.N.; Alio, A.P.; Wilson, R.E.; Marty, P.J.; Zoorob, R.; Salihu, H.M. Alcohol
Consumption During Pregnancy and Risk of Placental Abruption and Placenta Previa. Matern. Child Health J.
2011, 15, 670–676. [CrossRef] [PubMed]
Gundogan, F.; Gilligan, J.; Qi, W.; Chen, E.; Naram, R.; de la Monte, S.M. Dose Effect of Gestational Ethanol
Exposure on Placentation and Fetal Growth. Placenta 2015, 36, 523–530. [CrossRef] [PubMed]

Biomolecules 2019, 9, 669

13.

14.

15.

16.

17.
18.
19.
20.

21.

22.
23.

24.

25.
26.
27.
28.

29.

30.
31.

32.

17 of 19

Gundogan, F.; Elwood, G.; Mark, P.; Feijoo, A.; Longato, L.; Tong, M.; de la Monte, S.M. Ethanol-Induced
Oxidative Stress and Mitochondrial Dysfunction in Rat Placenta: Relevance to Pregnancy Loss. Alcohol. Clin.
Exp. Res. 2010, 34, 415–423. [CrossRef] [PubMed]
Lane, R.H.; Ramirez, R.J.; Tsirka, A.E.; Kloesz, J.L.; McLaughlin, M.K.; Gruetzmacher, E.M.; Devaskar, S.U.
Uteroplacental Insufficiency Lowers the Threshold towards Hypoxia-Induced Cerebral Apoptosis in
Growth-Retarded Fetal Rats. Brain Res. 2001, 895, 186–193. [CrossRef]
Basilious, A.; Yager, J.; Fehlings, M.G. Neurological Outcomes of Animal Models of Uterine Artery Ligation
and Relevance to Human Intrauterine Growth Restriction: A systematic review. Dev. Med. Child Neurol.
2015, 57, 420–430. [CrossRef] [PubMed]
Goeden, N.; Velasquez, J.; Arnold, K.A.; Chan, Y.; Lund, B.T.; Anderson, G.M.; Bonnin, A. Maternal
Inflammation Disrupts Fetal Neurodevelopment Via Increased Placental Output of Serotonin to the Fetal
Brain. J. Neurosci. 2016, 36, 6041–6049. [CrossRef]
Kodomari, I.; Wada, E.; Nakamura, S.; Wada, K. Maternal Supply of BDNF to Mouse Fetal Brain Through the
Placenta. Neurochem. Int. 2009, 54, 95–98. [CrossRef]
Brunton, P.J.; Russell, J.A. Endocrine Induced Changes in Brain Function During Pregnancy. Brain Res.
2010, 1364, 198–215. [CrossRef]
Burton, G.J.; Fowden, A.L. Review: The Placenta and Developmental Programming: Balancing Fetal Nutrient
Demands with Maternal Resource Allocation. Placenta 2012, 33, 23–27. [CrossRef]
Narasimhan, M.; Mahimainathan, L.; Rathinam, M.L.; Riar, A.K.; Henderson, G.I. Overexpression of Nrf2
Protects Cerebral Cortical Neurons from Ethanol-Induced Apoptotic Death. Mol. Pharmacol. 2011, 80, 988–999.
[CrossRef]
Patel, D.; Rathinam, M.; Jarvis, C.; Mahimainathan, L.; Henderson, G.; Narasimhan, M. Role for Cystathionine
γ Lyase (CSE) in an Ethanol (E)-Induced Lesion in Fetal Brain GSH Homeostasis. Int. J. Mol. Sci. 2018, 19, 1537.
[CrossRef] [PubMed]
Bosco, C.; Preedy, V.R.; Watson, R.R. Alcohol and Xenobiotics in Placenta Damage. Compr. Handb. Alcohol
Relat. Pathol. 2005, 2, 921–935.
Rosenberg, M.J.; Wolff, C.R.; El-Emawy, A.; Staples, M.C.; Perrone-Bizzozero, N.I.; Savage, D.D. Effects of
Moderate Drinking During Pregnancy on Placental Gene Expression. Alcohol 2010, 44, 673–690. [CrossRef]
[PubMed]
De La Monte, S.M.; Wands, J.R. Mitochondrial DNA Damage and Impaired Mitochondrial Function
Contribute to Apoptosis of Insulin-Stimulated Ethanol-Exposed Neuronal Cells. Alcohol. Clin. Exp. Res.
2001, 25, 898–906. [CrossRef]
Lyall, F. Development of The Utero-Placental Circulation: The Role of Carbon Monoxide and Nitric Oxide in
Trophoblast Invasion and Spiral Artery Transformation. Microsc. Res. Tech. 2003, 60, 402–411. [CrossRef]
Schneider, H. Oxygenation of the Placental-Fetal Unit in Humans. Respir. Physiol. Neurobiol. 2011, 178, 51–58.
[CrossRef]
Myatt, L. Review: Reactive Oxygen and Nitrogen Species and Functional Adaptation of the Placenta. Placenta
2010, 31, 66–69. [CrossRef]
Baczyk, D.; Audette, M.C.; Coyaud, E.; Raught, B.; Kingdom, J.C. Spatiotemporal Distribution of Small
Ubiquitin-Like Modifiers During Human Placental Development and in Response to Oxidative and
Inflammatory Stress. J. Physiol. 2018, 596, 1587–1600. [CrossRef]
Kay, H.H.; Grindle, K.M.; Magness, R.R. Ethanol Exposure Induces Oxidative Stress and Impairs Nitric
Oxide Availability in the Human Placental Villi: A Possible Mechanism of Toxicity. Am. J. Obstet. Gynecol.
2000, 182, 682–688. [CrossRef]
Devi, B.G.; Henderson, G.I.; Frosto, T.A.; Schenker, S. Effect of Ethanol on Mitochondria Morphologic and
Biochemical Integrity of The Fetal Rat Hepatocytes in Culture. Hepatology 1993, 19, 648–659. [CrossRef]
Chen, J.; Robinson, N.C.; Schenker, S.; Frosto, T.A.; Henderson, G.I. Formation of Hydroxynonenal Adducts
with Cytochrome c Oxidase in Rats Following Short-Term Ethanol Intake. Hepatology 1999, 29, 1792–1798.
[CrossRef]
Chen, J.; Petersen, D.R.; Schenker, S.; Henderson, G.I. Formation of Malondialdehyde Adducts in Livers
of Rats Exposed to Ethanol: Role in Ethanol-Mediated Inhibition of Cytochrome c Oxidase. Alcohol. Clin.
Exp. Res. 2000, 24, 544–552. [CrossRef] [PubMed]

Biomolecules 2019, 9, 669

33.
34.
35.

36.

37.

38.

39.
40.
41.

42.
43.

44.

45.

46.
47.

48.

49.
50.

51.

18 of 19

Ma, Q. Role of Nrf2 in Oxidative Stress and Toxicity. Annu. Rev. Pharmacol. Toxicol. 2013, 53, 401–426.
[CrossRef] [PubMed]
Gong, P.; Cederbaum, A.I. Nrf2 is Increased by CYP2E1 in Rodent Liver and Hepg2 Cells and Protects
Against Oxidative Stress Caused by CYP2E1. Hepatology 2006, 43, 144–153. [CrossRef] [PubMed]
Dong, J.; Sulik, K.K.; Chen, S.Y. Nrf2-Mediated Transcriptional Induction of Antioxidant Response in Mouse
Embryos Exposed to Ethanol In vivo: Implications for The Prevention of Fetal Alcohol Spectrum Disorders.
Antioxid. Redox Signal. 2008, 10, 2023–2033. [CrossRef] [PubMed]
Kumar, A.; Singh, C.K.; Lavoie, H.A.; Dipette, D.J.; Singh, U.S. Resveratrol Restores Nrf2 Level and Prevents
Ethanol-Induced Toxic Effects in The Cerebellum of a Rodent Model of Fetal Alcohol Spectrum Disorders.
Mol. Pharmacol. 2011, 80, 446–457. [CrossRef]
Bass, T.; Volpe, J.J. Ethanol in Clinically Relevant Concentrations Enhances Expression of Oligodendroglial
Differentiation but Has No Effect on Astrocytic Differentiation or DNA Synthesis in Primary Cultures.
Dev. Neurosci. 1989, 11, 52–64. [CrossRef]
Riar, A.K.; Narasimhan, M.; Rathinam, M.L.; Vedpathak, D.; Mummidi, S.; Henderson, G.I.; Mahimainathan, L.
Ethanol-Induced Transcriptional Activation of Programmed Cell Death 4 (Pdcd4) Is Mediated by GSK-3β
Signaling in Rat Cortical Neuroblasts. PLoS ONE 2014, 9, e98080. [CrossRef]
Delbridge, L.M.; Connell, P.J.; Harris, P.J.; Morgan, T.O. Ethanol Effects on Cardiomyocyte Contractility.
Clin. Sci. 2000, 98, 401–407. [CrossRef]
Toivari, M.; Mäki, T.; Suutarla, S.; Eklund, K.K. Ethanol Inhibits Ige-Induced Degranulation and Cytokine
Production in Cultured Mouse and Human Mast Cells. Life Sci. 2000, 67, 2795–2806. [CrossRef]
Narasimhan, M.; Rathinam, M.; Riar, A.; Patel, D.; Mummidi, S.; Yang, H.S.; Colburn, N.H.; Henderson, G.I.;
Mahimainathan, L. Programmed Cell Death 4 (PDCD4): A Novel Player in Ethanol-Mediated Suppression
of Protein Translation in Primary Cortical Neurons and Developing Cerebral Cortex. Alcohol. Clin. Exp. Res.
2013, 37, 96–109. [CrossRef] [PubMed]
Riar, A.K.; Narasimhan, M.; Rathinam, M.L.; Henderson, G.I.; Mahimainathan, L. Ethanol Induces Cytostasis
of Cortical Basal Progenitors. J. Biomed. Sci. 2016, 23, 6. [CrossRef] [PubMed]
Graham, C.H.; Hawley, T.S.; Hawley, R.G.; MacDougall, J.R.; Kerbel, R.S.; Khoo, N.; Lala, P.K. Establishment
and Characterization of First Trimester Human Trophoblast Cells with Extended Lifespan. Exp. Cell Res.
1993, 206, 204–211. [CrossRef] [PubMed]
Kilburn, B.A.; Wang, J.; Duniec-Dmuchowski, Z.M.; Leach, R.E.; Romero, R.; Armant, D.R. Extracellular
Matrix Composition and Hypoxia Regulate the Expression of HLA-G and Integrins in a Human Trophoblast
Cell Line. Biol. Reprod. 2000, 62, 739–747. [CrossRef] [PubMed]
Patten, A.R.; Fontaine, C.J.; Christie, B.R. A Comparison of the Different Animal Models of Fetal Alcohol
Spectrum Disorders and their Use in Studying Complex Behaviors. Front. Pediatr. 2014, 2, 93. [CrossRef]
[PubMed]
Rice, D.; Barone, S., Jr. Critical Periods of Vulnerability for the Developing Nervous System: Evidence from
Humans and Animal Models. Environ. Health Perspect. 2000, 108, 511–533.
Wong, C.T.; Wais, J.; Crawford, D.A. Prenatal Exposure to Common Environmental Factors Affects Brain
Lipids and Increases Risk of Developing Autism Spectrum Disorders. Eur. J. Neurosci. 2015, 42, 2742–2760.
[CrossRef]
Adamson, S.L.; Lu, Y.; Whiteley, K.J.; Holmyard, D.; Hemberger, M.; Pfarrer, C.; Cross, J.C. Interactions
Between Trophoblast Cells and the Maternal and Fetal Circulation in the Mouse Placenta. Dev. Biol.
2002, 250, 358–373. [CrossRef]
Gilpin, N.W.; Richardson, H.N.; Cole, M.; Koob, G.F. Vapor Inhalation of Alcohol in Rats. Curr. Protoc.
Neurosci. 2008, 9, 9–29.
Morton, R.A.; Diaz, M.R.; Topper, L.A.; Valenzuela, C.F. Construction of Vapor Chambers used to Expose Mice
to Alcohol During the Equivalent of all Three Trimesters of Human Development. J. Vis. Exp. 2014, 89, 51839.
[CrossRef]
Narasimhan, M.; Patel, D.; Vedpathak, D.; Rathinam, M.; Henderson, G.; Mahimainathan, L. Identification of
Novel MicroRNAs in Post-Transcriptional Control of Nrf2 Expression and Redox Homeostasis in Neuronal,
SH-SY5Y Cells. PLoS ONE 2012, 7, e51111. [CrossRef]

Biomolecules 2019, 9, 669

52.

53.
54.

55.
56.

57.

58.
59.

60.
61.

62.
63.

64.
65.

66.

67.

68.
69.

19 of 19

Narasimhan, M.; Riar, A.K.; Rathinam, M.L.; Vedpathak, D.; Henderson, G.; Mahimainathan, L. Hydrogen
Peroxide Responsive Mir153 Targets Nrf2/ARE Cytoprotection in Paraquat Induced Dopaminergic
Neurotoxicity. Toxicol. Lett. 2014, 228, 179–191. [CrossRef]
Dimauro, I.; Pearson, T.; Caporossi, D.; Jackson, M.J. A Simple Protocol for the Subcellular Fractionation of
Skeletal Muscle Cells and Tissue. BMC Res. Notes 2012, 5, 513. [CrossRef]
Morabito, C.; Guarnieri, S.; Catizone, A.; Schiraldi, C.; Ricci, G.; Mariggiò, M.A. Transient Increases in
Intracellular Calcium and Reactive Oxygen Species Levels in Tcam-2 Cells Exposed to Microgravity. Sci. Rep.
2017, 7, 15648. [CrossRef]
Kay, H.H.; Tsoi, S.; Grindle, K.; Magness, R.R. Markers of Oxidative Stress in Placental Villi Exposed to
Ethanol. J. Soc. Gynecol. Investig. 2006, 13, 118–121. [CrossRef]
Rodrigo, S.; Rodríguez, L.; Otero, P.; Panadero, M.I.; García, A.; Barbas, C.; Roglans, N.; Ramos, S.; Goya, L.;
Laguna, J.C.; et al. Fructose During Pregnancy Provokes Fetal Oxidative Stress: The Key Role of The Placental
Heme Oxygenase-1. Mol. Nutr. Food Res. 2016, 60, 2700–2711. [CrossRef]
Zhao, F.; Lei, F.; Yan, X.; Zhang, S.; Wang, W.; Zheng, Y. Protective Effects of Hydrogen Sulfide against
Cigarette Smoke Exposure-Induced Placental Oxidative Damage by Alleviating Redox Imbalance Via Nrf2
Pathway in Rats. Cell. Physiol. Biochem. 2018, 48, 1815–1828. [CrossRef]
Lee, H.M.; Choi, K.C. Cigarette Smoke Extract and Isoprene Resulted in the Induction of Apoptosis and
Autophagy in Human Placenta Choriocarcinoma JEG-3 Cells. Environ. Toxicol. 2018, 33, 178–190. [CrossRef]
Gu, H.; Li, H.; Zhang, L.; Luan, H.; Huang, T.; Wang, L.; Fan, Y.; Zhang, Y.; Liu, X.; Wang, W.; et al. Diagnostic
Role of MicroRNA Expression Profile in the Serum of Pregnant Women with Fetuses with Neural Tube
Defects. J. Neurochem. 2012, 122, 641–649. [CrossRef]
Erlebacher, A. Immunology of the Maternal-Fetal Interface. Annu. Rev. Immunol. 2013, 31, 387–411.
[CrossRef]
Genbacev, O.; Joslin, R.; Damsky, C.H.; Polliotti, B.M.; Fisher, S.J. Hypoxia Alters Early Gestation Human
Cytotrophoblast Differentiation/Invasion In vitro and Models the Placental Defects that Occur in Preeclampsia.
J. Clin. Investig. 1996, 97, 540–550. [CrossRef]
Rosario, G.X.; Konno, T.; Soares, M.J. Maternal Hypoxia Activates Endovascular Trophoblast Cell Invasion.
Dev. Biol. 2008, 314, 362–375. [CrossRef]
Sourisseau, T.; Georgiadis, A.; Tsapara, A.; Ali, R.R.; Pestell, R.; Matter, K.; Balda, M.S. Regulation of
PCNA and Cyclin D1 Expression and Epithelial Morphogenesis by the ZO-1-Regulated Transcription Factor
ZONAB/DbpA. Mol. Cell. Biol. 2006, 26, 2387–2398. [CrossRef]
Cao, X.; Hua, X.; Wang, X.; Chen, L. Exposure of Pregnant Mice to Triclosan Impairs Placental Development
and Nutrient Transport. Sci. Rep. 2017, 7, 44803. [CrossRef]
Banu, S.K.; Stanley, J.A.; Sivakumar, K.K.; Taylor, R.J.; Arosh, J.A.; Burghardt, R.C. Editor’s Highlight:
Exposure to CrVI during Early Pregnancy Increases Oxidative Stress and Disrupts the Expression of
Antioxidant Proteins in Placental Compartments. Toxicol. Sci. 2017, 155, 497–511. [CrossRef]
Xu, B.; Hua, J.; Zhang, Y.; Jiang, X.; Zhang, H.; Ma, T.; Zheng, W.; Sun, R.; Shen, W.; Sha, J.; et al. Proliferating
Cell Nuclear Antigen (PCNA) Regulates Primordial Follicle Assembly by Promoting Apoptosis of Oocytes
in Fetal and Neonatal Mouse Ovaries. PLoS ONE 2011, 6, e16046. [CrossRef]
Abbas, T.; Sivaprasad, U.; Terai, K.; Amador, V.; Pagano, M.; Dutta, A. PCNA-Dependent Regulation of P21
Ubiquitylation and Degradation Via the CRL4Cdt2 Ubiquitin Ligase Complex. Genes Dev. 2008, 22, 2496–2506.
[CrossRef]
Besson, A.; Dowdy, S.F.; Roberts, J.M. CDK Inhibitors: Cell Cycle Regulators and Beyond. Dev. Cell.
2008, 14, 159–169. [CrossRef]
Liu, Y.; Chen, G.; Ma, C.; Bower, K.A.; Xu, M.; Fan, Z.; Shi, X.; Ke, Z.J.; Luo, J. Overexpression of Glycogen
Synthase Kinase 3beta Sensitizes Neuronal Cells to Ethanol Toxicity. J. Neurosci. Res. 2009, 87, 2793–2802.
[CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).

